Evaluating patient data in the context of complementary information can provide comprehensive market insights for product strategy.
Vivian DeWoskin
Advertisement
GM of Commercial Life Sciences, Komodo Health
Articles by Vivian DeWoskin
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Study Claims Ozempic Lowers Biological Age
3
How will DTC Programs Impact PBMs?
4
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
5
